Nutritional genomics allows the use of nutrition research to determine nutritional interventions that enables gene expression that improves the health and wellbeing of individuals in the community. The future of science and medicine in disease progression in diabetes is now dependent on nutritional genomics that involve the anti-aging genes that are essential to prevent insulin resistance, circadian dysynchrony, hyperlipidemia, acute cardiovascular disease, nonalcoholic fatty liver disease (NAFLD) and neurodegenerative diseases. Genomic medicine is now important to the prevention of chronic diseases with its critical involvement in the immune system that involves toxic immune reactions connected to the acceleration of cardiovascular disease progression in diabetes in various communities.
REFERENCES:
Martins IJ. Genomic medicine and acute cardiovascular disease progression in diabetes. Research on Chronic Diseases. 2018) 2(1), 001–003.
Absolutely! and the first, metabolic expression of your genes is your 'metabolic type' that we can identify from your slightly extended blood type, which would include your secretor status. Attached is a medical article that explains the implications your metabolic 'type' has on your health status.
Statistically, only 20% of a each blood group are non-secretors, yet in the waiting rooms of physicians treating autoimmune, degenerative conditions, 80% of the patients in the waiting room are non- secretors.
In every subject that you are investigating, your blood group and secretor status determines your risks for developing autoimmune, degenerative diseases.
Attached are a few articles - realizing that your blood group and secretor status are the expression of your genome is the first step in genomic medicine!
- Badges
- Science topic
- Similar topics
- Medicine
- Epi
- Age Groups
- Children